In vivo transdermal iontophoretic delivery of growth hormone releasing factor GRF (1–44) in hairless guinea pigs
- 31 December 1992
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 18 (3) , 213-220
- https://doi.org/10.1016/0168-3659(92)90167-p
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Transdermal Delivery of Human Insulin to Albino Rabbits Using Electrical CurrentThe Lancet Healthy Longevity, 1989
- Iontophoresis-facilitated transdermal delivery of verapamil I. In vitro evaluation and mechanistic studiesJournal of Controlled Release, 1989
- Use of Continuous Subcutaneous Growth Hormone-Releasing Hormone (GHRH (1–29)NH2) Infusions to Augment Growth Hormone Secretion and to Promote GrowthActa Paediatrica, 1989
- lontophoretic Transport of a Homologous Series of Ionized and Nonionized Model Compounds: Influence of Hydrophobicity and Mechanistic InterpretationPharmaceutical Research, 1989
- Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteersClinical Pharmacology & Therapeutics, 1988
- Comparison Between the Lontophoretic and Passive Transport of Thyrotropin Releasing Hormone Across Excised Nude Mouse SkinJournal of Pharmaceutical Sciences, 1986
- Enhanced percutaneous absorption via iontophoresis I. Evaluation of an in vitro system and transport of model compoundsInternational Journal of Pharmaceutics, 1986
- lontophoretic Devices for Drug DeliveryPharmaceutical Research, 1986
- Physiological Studies with Somatocrinin, A Growth Hormone-Releasing FactorAnnual Review of Pharmacology and Toxicology, 1985
- LAGRAN program for area and moments in pharmacokinetic analysisComputer Programs in Biomedicine, 1983